This section is intended for Great Britain healthcare professionals. If you are a member of the public click here. If you have been prescribed ADCETRIS click here.
C-APROM/GB/ADCE/0087 - April 2022
Adverse events should be reported. In Great Britain, reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Takeda by e-mail AE.GBR-IRL@takeda.com.
Takeda, 
and ADCETRIS are registered trademarks of Takeda Pharmaceutical Company Limited.
Other trademarks are the property of their respective owners.
© Takeda UK Limited, 2024
Registered office: 1 Kingdom Street, London, W2 6BD, United Kingdom
Registered in England and Wales No. 3362860
C-APROM/GB/ADCE/0132 - September 2022
The link you have selected is not under the review or control of Takeda UK Ltd and, as such, the company does not endorse the content, its accuracy, or any practices or standards contained within it.
Please confirm you wish to follow this link.
The link you have selected is not under the review or control of Takeda Products Ireland Limited and, as such, the company does not endorse the content, its accuracy, or any practices or standards contained within it.
Please confirm you wish to follow this link.
You are now leaving the ADCETRIS.co.uk website. The link you have selected will now take you to the Takeda UK website.
Please confirm you wish to follow this link.
You are now leaving the ADCETRIS.co.uk website. The link you have selected will now take you to the Takeda global website. Takeda UK does not manage or maintain the content of the global website.
Please confirm you wish to follow this link.
You are now leaving the ADCETRIS.co.uk website. The link you have selected will now take you to the Takeda global website. Takeda UK does not manage or maintain the content of the global website.
Please confirm you wish to follow this link.
C-APROM/UK/ADCE/0094 - March 2021
